Eton Pharmaceuticals (ETON) Preferred Stock Liabilities (2017 - 2018)

Eton Pharmaceuticals has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $21.2 million for Q3 2018.

• Preferred Stock Liabilities for Q3 2018 came in at $21.2 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $21.2 million (changed N/A YoY), and the FY2017 annual result was $19.0 million, changed N/A from the prior year.
• Preferred Stock Liabilities came in at $21.2 million for Q3 2018 at Eton Pharmaceuticals, up from $19.0 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $21.2 million in Q3 2018 to a low of $19.0 million in Q4 2017.